A comparison of goal attainment scaling and the Canadian occupational performance measure for paediatric rehabilitation research

Pediatric Rehabilitation

Volumn 9, Issue 2, 2006, Pages 149-157

  Cusick, A ^a   McIntyre, S ^a,b   Novak, I ^a,b   Lannin, N ^a   Lowe, K ^c  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

^b The Spastic Centre of New South Wales   (Australia)

^c SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

Botulinum toxin Type A; Cerebral palsy; Instrumentation study; Outcome measures

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CANADA; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; GOAL ATTAINMENT; HEALTH PROGRAM; HUMAN; INSTRUMENTATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL RESEARCH; MENTAL PERFORMANCE; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; REHABILITATION; SPASTIC PARESIS; TRAINING; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FEMALE; HEMIPLEGIA; HUMANS; MALE; NEUROMUSCULAR AGENTS; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 32044450804     PISSN: 13638491     EISSN: 14645270     Source Type: Journal    
DOI: 10.1080/13638490500235581     Document Type: Article

References (49)

1. Hanna K, Rodger S. Towards family-centred practice in paediatric occupational therapy: A review of the literature on parent-therapist collaboration. Australian Occupational Therapy Journal 2002;49:4-24.
2. Judge SL, Parrette HP. Assistive technology for young children with disabilities: A guide to providing family-centered services. Cambridge: Brookline; 1998.
3. Humphrey R, Case-Smith J. Working with families. In: Case Smith J, Allen AS, Pratt P, editors. Occupational therapy for children. St Louis: Mosby; 1996. p 67-98.
4. Simpson RL. Working with parents and families of exceptional children and youth. Austin: Pro-Ed; 1996.
5. Henderson A. Self care and hand skills. In: Henderson A, Pehoski C, editors. Hand function in the child: Foundations for remediation. St Louis: Mosby Year Book; 1995. p 164-183.
6. Jeffrey LIH. Aspects of selecting outcome measures to demonstrate the effectiveness of comprehensive rehabilitation. British Journal of Occupational Therapy 1993;56:394-400.
7. King G, Law M, King S, Rosenbaum P. Parents' and service providers' perceptions of the family centredness of children's rehabilitation services. Physical and Occupational Therapy in Pediatrics 1998;18:21-40.
8. Wallen M, Doyle S. Performance indicators in paediatrics: The role of standardised assessments and goal setting. Australian Occupational Therapy Journal 1996;43:172-177.
9. Law M, Darrah J, Pollock N, King G, Rosenbaum P, Russell D, Palisano R, Harris S, Armstrong R, Watt J. Family-centred functional therapy for children with cerebral palsy: An emerging practice model. Physical and Occupational Therapy in Pediatrics 1998;18:83-102.
10. Bhatia M, Joseph B. Rehabilitation of cerebral palsy in a developing country: The need for comprehensive assessment. Pediatric Rehabilitation 2001;4:83-86.
11. Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: A double blind trial. Developmental Medicine and Child Neurology 1997;39:185-193.
12. Friedman A, Diamond M, Johnston M, Daffner C. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. American Journal of Physical Medicine and Rehabilitation 2000;79:53-59.
13. Denislic M, Meh D. Botulinum toxin in the treatment of cerebral palsy. Neuropediatrics 1995;26:249-521.
14. Mall V, Heinen F, Linder M, Philipsen A, Korinthenberg R. Treatment of cerebral palsy with botulinum toxin A: Functional benefit and reduction of disability. Three case reports. Pediatric Rehabilitation 1997;1:235-237.
15. Fosang A, Thomason P, McCoy A. Parent perception is a valid measure to evaluate changes in physical function in the child with cerebral palsy. Developmental Medicine and Child Neurology, Abstracts 1998;39:8-9.
16. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning 1979;2:197-207.
17. Heinen F, Linder M, Mall V, Kirschner J, Korinthenberg R. Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A - the parents' view of functional outcome. European Journal of Neurology 1999;6:S47-S50.
18. Cohn E, Miller LJ, Tickle-Degnen L. Parental hopes for therapy outcomes: Children with sensory modulation disorders. American Journal of Occupational Therapy 2000;54:36-43.
19. Wehman T, Gilkerson L. Parents of young children with special needs speak out: Perceptions of early intervention services. Infant-Toddler Intervention: The Transdisciplinary Journal 1999;9:137-167.
20. Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N. Canadian occupational performance measure. Toronto: CAOT Publications, ACE; 2000.
21. Law M, Baptiste S, McColl MA, Opzoomer A, Polatajko H, Pollock N. The Canadian occupational performance measure: An outcome measure for occupational therapy. Canadian Journal of Occupational Therapy 1990;57:82-87.
22. Law M, Russell D, Pollock N, Rosenbaum P, Walter S, King G. A comparison of intensive neurodevelopmental therapy plus casting and a regular occupational therapy program for children with cerebral palsy. Developmental Medicine and Child Neurology 1997;39:664-670.
23. Wallen M, O'Flaherty SJ, Waugh MCA. Functional outcomes of intra-muscular Botulinum toxin A in the upper limbs of children with cerebral palsy: A phase II trial. Archives of Physical Medicine and Rehabilitation 2004;85:192-200.
24. Lowe K, Novak I, Cusick A. Low dose/high concentration localized intramuscular Botulinum toxin A improves upper limb movement and function in children with cerebral palsy. Developmental Medicine and Child Neurology; in press.
25. Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating community mental health programs. Community Mental Health Journal 1968;4:442-453.
26. Kiresuk TJ, Smith A, Cardillo JE. Goal attainment scaling: Applications, theory, and measurement. Hillsdale, NJ: Lawrence Erlbaum Associates; 1994.
27. Ottenbacher KJ, Cusick A. Goal attainment scaling as a measure of clinical service evaluation. American Journal of Occupational Therapy 1990;44:519-525.
28. Waugh MCA, Wallen MA, O'Flaherty SJ. Botulinum toxin A injections in the upper limbs of children with cerebral palsy: A pilot project. Developmental Medicine and Child Neurology 2000;42:S34.
29. Boyce W, Gowland C, Russell D, Goldsmith CH, Rosenbaum P, Plews N, Lane M. Consensus methodology in the development and content validation of a gross motor performance measure. Physiotherapy Canada 1993;45:94-100.
30. McColl MA, Paterson M, Doubt L, Law M. Validity and community utility of the Canadian occupational performance Measure. Canadian Journal of Occupational Therapy 1998;67:22-30.
31. Carswell A, Polatajko H, Law M, Baptiste S, McColl MA, Pollock N. A self-instructional package for the COPM. Toronto: CAOT Publications; 1996.
32. Kiresuk T, Sherman R. A reply to the critique of goal attainment scaling. Social Work Research and Abstracts 1977;13:9-11.
33. Choate R, Smith A, Cardillo J, Thompson L. Training in the use of goal attainment scaling. Community Mental Health Journal 1981;17:171-181.
34. Cytrynbaum S, Ginath Y, Birdwell J, Brandt L. Goal attainment scaling: A critical review. Evaluation Quarterly 1979;3:5-40.
35. Grenville J, Lyne P. Patient-centered evaluation and rehabilitation care. Journal of Advanced Nursing 1995;22:965-972.
36. Arens LJ, Leary PM, Goldschmidt RB. Experience with botulinum toxin in the treatment of cerebral palsy. South African Medical Journal 1997;87:1001-1003.
37. Boyd RN, Graham HK. Botulinum toxin A in the management of children with cerebral palsy: Indications and outcome. European Journal of Neurology 1997;4:S15-S22.
38. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomised, double-blind, placebo-controlled trial. Neurology 1996;46:1306-1310.
39. Binder A. Restrictions on statistics imposed by method of measurement: Some reality, some myth. Journal of Criminal Justice 1984;12:467-481.
40. Labovitz S. Some observations on measurement and statistics. Social Forces 1967;46:467-481.
41. Labovitz S. The assignment of numbers to rank order categories. American Sociological Review 1970;35:515-524.
42. Zumbo BD, Zimmerman DW. Is the selection of statistical methods governed by level of measurement? Canadian Psychology 1993;34:390-399.
43. Rosnow RL, Rosenthal R. Computing contrasts, effect sizes, and counternulls on other people's published data: General procedures for research consumers. Psychological Methods 1996;1:331-340.
44. Rockwood K, Graham JE, Fay S. Goal setting and attainment in Alzheimer's disease patients treated with donepezil. Journal of Neurology, Neurosurgery and Psychiatry 2002;73:500-507.
45. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: A critical review and recommendations. Journal of Clinical Epidemiology 2000;53:459-468.
46. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
47. Lowe NK, Ryan-Wenger NM. Beyond Cambell and Fiske: Assessment of convergent and discriminant validity. Research in Nursing and Health 1992;15:67-75.
48. Nunally J. Psychometric theory. New York: McGraw Hill; 1978.
49. Babbie E. Unobtusive research. In: Babbie E, editor. The practice of social research. Chapter 11. Belmont: Wadsworth; 1983. p 265-296.